• 

  New Genetic Risk Factor Identified for Rare Form of FTD
• 

  Parkinson’s-Linked Protein May Drive Faster Alzheimer’s Progression in Women
• 

  New Once-Daily Parkinson’s Drug Tavapadon Nears FDA Decision
• 

  An In-Ear Device Could Track Waste Clearance in the Brain
• 

  FDA Approves New Drug for Alzheimer’s Agitation
• 

  Could A Single Infusion of Stem Cells Treat Frailty?
• 

  Rethinking Parkinson’s: A Disorder of Brain Networks Rather than Movement
• 

  GLP-1 Drugs and Brain Health: Can They Reduce Alzheimer’s Risk?
• 

  Review Questions Impact of Anti-Amyloid Drugs
• 

  Most Older Adults Would Take an Alzheimer’s Blood Test, Study Finds
• 

  New Drug for Rare Childhood Dementia Wins FDA Accelerated Approval
• 

  Does CTE Cause Aggression? Study Finds Link to Dementia Instead
• 

  Targeting the ApoE4 Gene to Treat Alzheimer’s
• 

  Can Brain Training Reduce Dementia Risk 20 Years Later?
• 

  Could Long COVID Brain Changes Signal Future Cognitive Decline?

12Next